Novo Nordisk to launch cheaper Ozempic copy in South Africa

Novo Nordisk is launching Extensior, a cheaper semaglutide copy, in South Africa to expand access to GLP-1 treatment for type 2 diabetes patients. The move signals a producer's own-brand generic strategy to capture price-sensitive emerging markets.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.